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A number of investigations have implied in recent
years that a relationship exists between adenosine
3', 5'-cyclic monophosphate (cyclic AMP) and the
growth of cells. Numerous experimental systems
have been used to examine several different cell
types. The result has been some definitive in-
formation about how cells divide, what role cyclic
AMP plays in cell replication, and which periods
of the cell cycle are affected by cyclic AMP.
This review article will primarily consider the
role of cyclic AMP in mammalian cells in culture
in both resting and dividing states . The examina-
tion of cultured cells has the advantage that the
intracellular levels of cyclic AMP and the enzyme
activities which may be influenced either directly
or indirectly by this cyclic nucleotide can be
examined as a function of a reasonably well-
defined chemical medium. Furthermore, the role
that cyclic AMP exerts in cells that have been
shifted from the resting to the dividing state may
be assessed. Because of the many different ap-
proaches that have been used, some of the in-
formation obtained appears to be contradictory
(although it still suggests a role for cyclic AMP
in cellular proliferation). The purpose of this re-
port is to discuss individually the results that sup-
port specific aspects of the action of cyclic AMP
at the morphological and molecular levels.
IS CYCLIC AMP A MITOGEN?
The capacity of cyclic AMP to cause cells to con-
vert or "transform" from a resting into a dividing
REV I E W
state must, by definition, be confined to a study
of those cells that are physiologically repressed .
Consequently, such investigations have been per-
formed primarily in animal and human lympho-
cytes. These cells represent a unique system to
study the mitogenic potential of cyclic AMP be-
cause they can be maintained in vitro in the
resting state and will not undergo appreciable
cellular DNA synthesis or mitotic division unless
stimulated by a mitogenic substance (Nowell,
1960).
MacManus and Whitfield (1970) demonstrated
that physiological concentrations . of cyclic AMP
(10-8-10-6 M) added to rat thymus cultures of
lymphocytes stimulated DNA synthesis and
mitotic division (see Table I) . Additions of caf-
feine (0.8 mM), which presumably inhibits cyclic
AMP phosphodiesterase under the conditions
used, also increased the percentage of mitotic cells.
Additions of cyclic AMP at concentrations greater
than 10-6 M, however, inhibited cell growth .
These results in vitro were confirmed subsequently
in vivo when a single intraperitoneal injection of
cyclic AMP or its dibutyryl derivative in Col-
cemid-treated rats was shown to increase the
number of bone marrow and thymus cells that
entered mitosis (Rixon et al., 1970). The optimal
dose of the cyclic nucleotides for this stimulatory
activity was 5 mg/kg animal weight, and doses less
than 2 mg/kg or more than 7 mg/kg produced
essentially no activity. Since AMP-5' had no effect,
the stimulatory action appeared to be a property
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of this cyclic nucleotide. Furthermore, the con-
centrations of cyclic AMP that produce the ap-
propriate mitotic response were found to approxi-
mate those that stimulated mitosis of thymic
lymphocytes in vitro. Collectively, these results
indicate that cyclic AMP is stimulating a cell that
has already been programmed to undergo DNA
synthesis and cell division. Thus, the role of
cyclic AMP in thymocyte proliferation may be a
promotional or auxiliary function rather than a
mitogenic one.
Cross and Ord (1971) demonstrated that addi-
tions of Ns, 02-dibutyryl cyclic AMP (dibutyryl
cyclic AMP) at concentrations of 10-5-10-4 M,
stimulated DNA synthesis in porcine peripheral
blood lymphocytes. The patterns of RNA and
DNA synthesis, which were derived from the in-
corporation of labelled uridine into RNA and
labelled thymidine into DNA, were identical to
the patterns obtained when these cells were stimu-
lated with phytohemagglutinin (PHA) . Unfor-
tunately, neither the nucleotide pool sizes, DNA
content, nor mitotic indices were measured in
these studies. Thus, the possibility exists that the
rates of incorporation of labelled precursors do not
accurately indicate the true synthetic rates for
RNA and DNA. Interestingly, an increase in the
size and specific radioactivity of the intracellular
phosphate pool was observed after stimulation
with both PHA and dibutyryl cyclic AMP. Also,
an almost immediate increase in the specific radio-
activity of phosphate incorporation into histone
and histone kinase activity occurred within 30
min after stimulation . These data suggested to
Cross and Ord (1971) that the activation of his-
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TABLE I
Effects of Cyclic AMP on Nondividing Cells
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tone kinase by cyclic AMP is one of the early
events associated with the mitogenic stimulation
of lymphocytes. Hirschhorn et al . (1969) observed
that cyclic AMP (at concentrations of 10 -6-10-5
M) added to unstimulated human peripheral
blood lymphocytes, produced a small but repro-
ducible increase in DNA synthesis. The extent of
synthesis as indicated by the incorporation of
thymidine into DNA was only 2 % of that observed
with PHA. This result may indicate that cyclic
AMP affects a cell type in the culture other than
lymphocytes or, alternatively, a particularly small
subpopulation of lymphocytes . They observed
further that cyclic AMP, dibutyryl cyclic AMP,
and theophylline in concentrations of 10 -4-
10-3 M inhibited the DNA synthesis stimulated by
PHA. In other studies (Johnson and Abell, 1970),
additions of either dibutyryl cyclic AMP or cyclic
AMP to unstimulated human peripheral blood
lymphocytes from either normal donors or patients
with chronic lymphocytic leukemia did not in-
crease the rate of DNA synthesis.
Averner et al. (1972) demonstrated that cyclic
AMP at concentrations of 10-5-10-4 M stimulated
the incorporation of labeled uridine into RNA but
did not increase the incorporation of labeled thy-
midine into DNA in horse lymphocytes . Cyclic
AMP increased the rate of RNA synthesis by 40-
50% in these lymphocytes in either the absence or
presence of PHA. Dibutyryl cyclic AMP, in con-
trast, inhibited RNA synthesis under these con-
ditions. Averner et al. (1972) also found that cyclic
AMP did not affect either the rate of uridine up-
take into cells, the synthesis of uridine triphos-
phate, or the rate of degradation of RNA. Conse-
Cell type Additions (Concentrations) Response Reference
Thymocytes Cyclic AMP (10-8 to 10-6 M) Stimulated DNA synthesis MacManus and
Cyclic AMP (Above 10-4 M) Inhibited DNA synthesis Whitfield (1970)
Lymphocytes Dibutyryl cyclic AMP (10-5- Stimulated DNA synthesis Cross and Ord
(porcine) 10-4 M) (1971)
Lymphocytes Cyclic AMP (10-e-10-5 M) Slightly stimulated DNA Hirschhorn et al.
(human) synthesis (1969)
Lymphocytes Cyclic AMP (10-5-10-4 M) No effect on DNA synthesis Averner et al.
(horse) Cyclic AMP (10-5-l0-4 M) Stimulated RNA synthesis (1972)
Dibutyryl cyclic AMP (10-5- Inhibited RNA synthesisquently, they concluded that cyclic AMP had a
direct effect upon the transcription but not repli-
cation of DNA.
THE EFFECT OF INCREASING
CYCLIC AMP LEVELS ON
CELL DIVISION
The intracellular level of cyclic AMP is determined
primarily by adenylate cyclase, which catalyzes
the synthesis of cyclic AMP from ATP, and cyclic
AMP phosphodiesterase, which cleaves cyclic
AMP to AMP-5' (Robison, 1972). The intra-
cellular level of cyclic AMP may be readily in-
creased either by stimulating adenylate cyclase
activity, with the addition of a hormone or drug
which mediates its action through cyclic AMP, or
by the addition of an inhibitor of cyclic AMP
phosphodiesterase such as a methylxanthine . Yet
another method of increasing the intracellular
levels of cyclic AMP is the addition of cyclic AMP
or dibutyryl cyclic AMP to cells . In this method,
it is presumed that cyclic AMP or dibutyryl cyclic
AMP penetrates the cell membrane, thus directly
increasing the intracellular levels of this cyclic
nucleotide.
Studies in this laboratory (Abell et al ., 1970;
Johnson and Abell, 1970) have shown that addi-
tions of isoproterenol, dibutyryl cyclic AMP,
and cyclic AMP greatly inhibit DNA synthesis in
PHA-stimulated lymphocytes from patients with
chronic lymphocytic leukemia at concentrations
(10-5 M) that have essentially no effect on normal
lymphocytes (See Table II) . When higher con-
centrations (10`'-10-3 M) of these drugs were
added, however, inhibition of DNA synthesis was
observed also in normal lymphocytes. Studies by
Smith et al. (1971a) demonstrated that isopro-
terenol elevated the cyclic AMP concentration
above that observed in PHA stimulated cells and
treatment with dibutyryl cyclic AMP at 10-4 M
concentrations resulted in pronounced inhibition
of DNA synthesis (Smith et al., 1971 b) .
Krug et al. (1972) found that resting lympho-
cytes, which contain only approximately six
insulin binding sites, attain approximately 350
insulin binding sites on the cell surface within
24-48 h after stimulation with concanavalin A .
With low concentrations, which stimulated DNA
synthesis, it was further found that concanavalin
A inhibited adenylate cyclase activity in broken
cell preparations. Conversely, in high concentra-
tions, concanavalin A inhibited DNA synthesis and
stimulated adenylate cyclase activity. These in-
vestigators suggested that it would be of particular
interest to determine if the insulin receptors are
the same as the membrane glycoproteins observed
by Scott and Marchesi (1972), which appear on
the surface of lymphocytes within 24 h after PHA
addition.
Ryan and Heidrick (1968) found that cyclic
AMP and dibutyryl cyclic AMP inhibited the
growth of HeLa and L cells. Interestingly, di-
butyryl cyclic AMP was less inhibitory than the
parent nucleotide cyclic AMP. Cultures of human
diploid fibroblasts as well as a number of lines of
mouse fibroblasts have also been employed to
study the effects of cyclic AMP, dibutyryl cyclic
AMP, and theophylline on cell proliferation (Burk,
1968; Johnson et al., 1971 ; Sheppard, 1971).
These compounds inhibited cell growth and con-
verted at least some of the morphological proper-
ties of virally transformed cells to normal pheno-
types. Collectively, these studies strongly indicate
that the elevation of the intracellular levels of
cyclic AMP, induced either by stimulation of
adenylate cyclase, inhibition of phosphodiesterase,
or by cyclic AMP additions, inhibits cell growth .
INTRACELLULAR LEVELS OF
CYCLIC AMP AND THE RATE OF
DNA SYNTHESIS
The relationship between the intracellular levels
of cyclic AMP and the rate of DNA synthesis (See
Table III) has been examined in a number of cell
lines (Otten et al., 1971). In studies performed on
fibroblasts during logarithmic growth, they
reasoned that if cyclic AMP inhibits the growth of
fibroblasts, then slowly growing cells should have
higher intracellular levels of cyclic AMP than
rapidly growing cells. In a study of 13 different
cell lines, it was found that the intracellular level
of cyclic AMP was inversely proportional to the
rate of DNA synthesis. Furthermore, when 3T3
cells were transformed with simian virus 40
(SV40), there was a corresponding decrease in
cyclic AMP levels which correlated directly with
increased growth rate of the cells .
Marks and Grimm (1972) determined the intra-
cellular cyclic AMP levels of epidermis in mice
that were maintained in a dark and light cycle .
Cyclic AMP levels in the dorsal epidermis fluctu-
ated with a pronounced diurnal rhythm, reaching
a maximum during the resting phase and decreas-
ing to a minimum during the activity phase of the
ABELL AND MONAHAN Role of Cyclic AMP in Regulation of Mammalian Cell Division
	
551Lymphocytes
(human leu-
kemic)
W138
HeLa, L, HEP2,
and F1 amnion
BHK 21/13, PyV,
and BR7
Sarcoma and fi-
broblasts
TABLE II
Effects of Increasing Intracellular Levels of Cyclic AMP in Dividing Cells
(10-4 M)
Aminophylline (10_5-
10-s M)
mice. Thus, high levels of cyclic AMP were found
to coincide with low mitotic activity .
Sheppard (1972) also examined cyclic AMP
levels in normal and transformed fibroblasts main-
tained in vitro. The steady state levels of cyclic
AMP in normal density dependent fibroblasts
were twice as high as those in a corresponding
viral and a spontaneously transformed fibroblast
culture. He also examined several components,
including serum (Todaro et al ., 1965), proteases
(Burger, 1970; Sefton and Rubin, 1970), and in-
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(1971 b)
sulin (Temin, 1967), that influence growth and
may affect the intracellular levels of cyclic AMP.
A reduction of the intracellular cyclic AMP levels
occurred after confluent monolayers of normal
3T3 cells were exposed to serum, trypsin, and in-
sulin. Furthermore, prostaglandin E l (PGE1) in-
creased the intracellular cyclic AMP levels in
cultured cells and transformed 3T3 cells . PGE1
also inhibited cellular growth in virally and spon-
taneously transformed cells (Sheppard, 1972) .
Thus, cyclic AMP levels and cell growth rate ap-
(10-4-10-3 M)
Theophylline (10-3 M)
3T3 Dibutyryl cyclic AMP Restoration of contact- Sheppard (1971)
3T6 (10-5-10-3 M) inhibited growth
PyV-3T3 Theophylline (10-3 M)
Epidermal cells Dibutyryl cyclic AMP (3-5 Inhibited cell growth Voorhees and Duell
X 10-3 M) (1971)
Theophylline (5 X 10-3 M)
Cell type Additions (Concentrations) Response Reference
Lymphocytes Isoproterenol (10-4-10-'M) Inhibited DNA synthesis Abell et al. (1970) ;
(human) Dibutyryl cyclic AMP Johnson and Abell
(10-4-10-3 M) (1970)
Cyclic AMP (10-4-10-3 M)
Lymphocytes Isoproterenol (10-5-10-'M) Inhibited DNA synthesis Smith et al. (1971 a) ;
(human) Dibutyryl cyclic AMP Smith et al.
Isoproterenol (10-5 M)
Dibutyryl cyclic AMP
Inhibited DNA synthesis Abell et al. (1970) ;
Johnson and Abell
(10-5 M) (1970)
Cyclic AMP (10-5 M)
Cyclic AMP (10-4 M) Slightly inhibited cell Heidrick and Ryan
growth (1970)
Cyclic AMP (10-4 M) Inhibited cell growth Heidrick and Ryan
(1970)
Cyclic AMP (10-4 M) Inhibited cell growth Burk (1968)
Cyclic AMP (3 X 10-3 M) Restoration of pheno- Johnson et al. (1971)
Butyryl cyclic AMP (10-4- typically normal mor-
10-3 M) phology
Dibutyryl cyclic AMPTABLE III
Relationship between Intracellular Cyclic AMP Levels and Cell Growth
parently are altered or controlled by a number of
different factors.
Heidrick and Ryan (1971) investigated the
intracellular levels of cyclic AMP, cyclic AMP
phosphodiesterase, and the rate of growth in
several cell types including L, HeLa, HEP2, Fl
amnion, Ehrlich ascites, W138, and fibro 5 . They
found a direct relationship between the levels of
cyclic AMP and the doubling time of these cells,
but no correlation between phosphodiesterase
activities and growth rate. Furthermore, two non-
neoplastic cell lines had considerably higher levels
of cyclic AMP than the transformed lines. Heidrick
and Ryan (1971) suggested that the changes in
cyclic AMP levels may be related to the phenome-
non of cell contact inhibition. In another study by
Froehlich and Rachmeler (1972), the levels of
cyclic AMP were measured in human diploid
fibroblasts. These cells, like the mouse fibroblast,
demonstrate density dependent inhibition of cell
growth. DNA synthesis in nonconfluent cultures
and in contact-inhibited cultures, was stimulated
by refeeding with fresh media and was found to be
inhibited by exogenous cyclic AMP . Of more
relevance, however, was the finding that the intra-
cellular levels of cyclic AMP decreased when cells
were stimulated to divide by adding fresh serum.
These investigators concluded that their data sup-
ported the concept that cyclic AMP is related to
the contact inhibition of cell proliferation . Al-
though the mechanism for the inhibitory action of
cyclic AMP is presently unknown, Froehlich and
Rachmeler (1972) suggest that cyclic AMP may
(1972)
function to control cell growth through the activa-
tion of a protein kinase . Substrates that are phos-
phorylated include such proteins as histones
(Langan, 1971) and phosphorylase (Robison et al .,
1971), as well as others (Kuo and Greengard,
1969). Although the physiological function of
phosphorylation of proteins is not clearly under-
stood at the present time, alterations of proteins in
this fashion may contribute to the control of cell
growth at the transcriptional level by affecting the
RNA produced (as shown in a bacterial system by
Pastan and Perlmann, 1972) or the translational
level by regulating protein synthesis (Wicks, 1969 ;
Barnett and Wicks, 1971 ; Walton et al., 1971).
An interesting report by Seifert and Paul (1972)
compared the levels of cyclic AMP in sparse and
dense cultures of both growing and quiescent 3T3
cells. In this study, 3T3 cells were cultured in
medium containing 1 % or 10 % calf serum and
were analyzed for cyclic AMP content during
logarithmic growth and in the resting phase when
the cells became quiescent. When cells were grown
in 10% calf serum, they reached a saturation
density of approximately 107 cells/dish, whereas
when they were grown in 1 % serum, they reached
a saturation density of 1 .5 X 11 5 cells/dish. This
result suggested that cell growth is dependent
upon the amount of serum that is supplied to the
medium. Interestingly, quiescent 3T3 cells, which
were independent of cell-to-cell contact (grown in
1 % serum) had an intracellular level of cyclic
AMP that was twice that of growing 3T3 cells .
When serum was added to quiescent cultures of
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Cell type Growth conditions Growth rate
Intracellular
cyclic AMP Reference
Fibroblasts Comparison of loga- Increased Decreased Otten et al. (1971)
rithmically growing
cells
3T3 Transformed with SV40 Increased Decreased Otten et al. (1971)
Fibroblasts Virally transformed Increased Decreased Sheppard (1972)
Transformed cells PGE1 addition Decreased Increased Sheppard (1972)
L, HeLa, HEP2, Fl am- Comparison of loga- Decreased Increased Heidrick and Ryan
nion, Ehrlich ascites, rithmically growing (1971)
W138, and fibro 5 cells
Diploid human fibroblasts Contact-inhibited cells Increased Decreased Froehlich and
refed with fresh serum Rachmeler
(1972)
3T3 Growth to quiescence Decreased Increased Seifert and Paul3T3 cells, a decrease in cyclic AMP levels was
observed within 10 min, a finding which is in
agreement with that observed by Sheppard (1971) .
Seifert and Paul (1972) concluded that the control
of cyclic AMP levels in 3T3 cells is not affected by
contact between cells and that serum factors are
involved in their regulation . Apparently a serum
growth factor is essential for 3T3 cells but is not
required by transformed cells for growth (Paul
et al., 1971) . When this growth factor is depleted,
cyclic AMP levels increase and the cells become
quiescent.
CYCLIC AMP LEVELS IN THE
STAGES OF THE MAMMALIAN
CELL CYCLE
Smith et al. (1971 a), using a radioimmunoassay
technique, found that intracellular cyclic AMP
levels in normal lymphocytes increase significantly
after the addition of PHA. Within 24 h, however,
cyclic AMP wa.- reduced to below baseline values .
These results suggest that cyclic AMP may repre-
sent a signal for mitotic division and that an in-
crease in the intracellular level of cyclic AMP is
required early in the G1 state of the cell cycle. In
contrast, however, Novogrodsky and Katchalski
(1970) found that PHA did not increase either the
level of cyclic AMP or adenylate cyclase activity
in rat lymph node lymphocytes. Also Makman
(1971) demonstrated that PHA substantially de-
decreased adenylate cyclase activity in homoge-
nates of mouse and rat lymphoid tissues. In still
another study, Hadden et al. (1972) found that
additions of purified preparation of PHA and
concanavalin A did not change the intracellular
concentration of cyclic AMP in human peripheral
blood lymphocytes, but did produce a 10- to 50-
fold increase in cyclic GMP concentrations within
20 min after stimulation . They found further that
small increases in cyclic AMP produced by the
addition of PHA (similar to those observed by
Smith et al., 1971 a) may be attributed to the
agglutinating components in the preparation.
They proposed that the increase in cyclic GMP
levels may be a consequence of the response of
cells to a mitogenic stimulant . Since these findings
have not been investigated more extensively, the
question of whether cyclic AMP or cyclic GMP is
acting as an early messenger for the initiation of
DNA synthesis still remains somewhat obscure.
In our laboratory, we have found that 5 min after
PHA is added to normal human lymphocytes,
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intracellular cyclic AMP rises slightly and after
60 min, it is doubled. This level of cyclic AMP
subsequently decreases within 24 h to below that
observed in unstimulated cells and remains low
during the replication of DNA (Monahan and
Abell, unpublished observations) .
In another study using synchronized HeLa cells,
Zeilig et al. (1972) measured the concentration of
cyclic AMP in each stage of the cell cycle . Specific
fluctuations occurred throughout the cell cycle
with the lowest levels of cyclic AMP reached dur-
ing mitosis. Of particular interest, however, was
the observation that when a specific inhibitor of
cyclic AMP phosphodiesterase was added at the
beginning of G2, mitotic division was delayed by
3 h. Millis et al. (1972) also observed that addi-
tions of dibutyryl cyclic AMP caused a delay in
mitosis in synchronized human lymphoid cells. In
addition, Sheppard and Prescott (1972) have
studied cyclic AMP levels in Chinese hamster
ovary cells synchronized by mitotic shake-off. They
observed that in comparison to the S stage, mitotic
cells had a depressed cyclic AMP level, early G I
cells had an elevated cyclic AMP level, and late
G1 cells possessed a cyclic AMP level similar to
cells that were in DNA synthesis (S phase) . With
use of the isoleucine deficiency technique, which
blocks cells in the GI period by the inhibi-
tion of protein synthesis, a depressed level of
cyclic AMP was observed. These results suggest
that protein synthesis is required for the estab-
lishment of appropriate levels of cyclic AMP.
Furthermore, since adenylate cyclase is known to
be more sensitive to hormone stimulation during
mitosis (Makman and Klein, 1972), Sheppard and
Prescott (1972) suggested that the changes in the
cell surface during this period may also be ac-
companied by changes in the activities of enzymes
associated with the plasma membrane . In con-
junction with this change, the activity of cyclic
nucleotide phosphodiesterase, which also influ-
ences the level of cyclic AMP, may fluctuate con-
siderably over the cell cycle . Such determinations
have not been performed in synchronized cells.
Sheppard and Prescott (1972) also suggested that
a decrease in cyclic AMP could lead to activation
or synthesis of adenylate cyclase. Within this con-
text, it would also be of interest to know the levels
of cyclic GMP within the various phases of the cell
cycle. As discussed above, Hadden et al . (1972)
demonstrated that cyclic GMP concentrations are
elevated within 20 min after PHA stimulation .They suggest that this is an immediate signal pro-
duced by the mitogen which may, in fact, transfer
information from the cell surface to the nucleus of
the cell where DNA transcription occurs . Assays of
cyclic GMP throughout the cell cycle may provide
insight into the specificity and role of this cyclic
nucleotide.
THE RELATIONSHIP BETWEEN
INTRACELLULAR CYCLIC AMP
LEVELS AND MALIGNANT
CELL GROWTH
Numerous studies have been performed to estab-
lish a relationship between cyclic AMP and neo-
plasia. Agents which presumably increase intra-
cellular cyclic AMP levels such as isoproterenol,
dibutyryl cyclic AMP, and cyclic AMP greatly
inhibit DNA synthesis in PHA stimulated lympho-
cytes from patients with chronic lymphocytic
leukemia at concentrations which have essentially
no effect on normal lymphocytes (Abell et al.,
1970; Johnson and Abell, 1970) . The inhibition
obtained with dibutyryl cyclic AMP was essen-
tially the same as that obtained with isoproterenol .
Cyclic AMP produced less inhibition than either
isoproterenol or dibutyryl cyclic AMP at the same
concentrations. The inhibition obtained with all
of the drugs was greater when they were added
before DNA synthesis began but after the cells were
shifted from a resting to a dividing state . This ob-
servation implies that an event in G 1 is particularly
sensitive to cyclic AMP. Furthermore, additions
of theophylline potentiated the effects of isopro-
terenol. In other studies, Heidrick and Ryan
(1970) have shown that cyclic AMP inhibited the
growth of several cell lines (HeLa, L, HE P2, and
F 1 amnion) but had only a slight effect on one
nonmalignant cell line (W138) . Cyclic GMP
produced a similar inhibition of growth in both
cell types.
As discussed previously, the direct relationship
between cyclic AMP levels and cell doubling time
(Goggins et al., 1972; Otten et al., 1971) has pro-
moted the idea that at least some aspects of ab-
normal behavior of cultured transformed cells are
due to the cells' inability to maintain normal
amounts of this nucleotide. Other studies have also
been performed in hepatoma cell lines (van Wijk
et al., 1972). Some hepatomas transplanted in
vivo have low adenylate cyclase activities which
are insensitive to glucagon, whereas others are
quite sensitive to this hormone and appear to be-
have like normal liver cells (Emmelot and Bos,
1971 ; Butcher et al., 1972). Unfortunately, ade-
quate comparisons have not been possible because
of the limitations of growing parenchymal cells
continuously in culture. Furthermore, in most of
the cell types that have been studied to date,
measurements of all of the major determinants of
the cyclic AMP system (adenylate cyclase, intra-
cellular cyclic AMP levels, and cyclic AMP phos-
phodiesterase in the neoplastic state and in the
cells or origin) have not yet been performed .
An interesting model for the study of cells that
are rapidly growing but are not malignant is
psoriasis. Voorhees and his co-workers (Voorhees
and Duell, 1971 ; Powell et al., 1971 ; Duell et al.,
1971) have found differences in adenylate cyclase
activity between the fibroblasts obtained from nor-
mal donors and patients with psoriasis. Further-
more, additions of cyclic AMP reduce epidermal
growth. These investigators suggest that psoriasis
may be a "polygenic environmentally-induced
defect in the adenylate cyclse AMP cascade"
(Voorhees and Duell, 1971) .
Taken together, all of these studies directly con-
firm or suggest that intracellular cyclic AMP levels
are lower in malignant cells and that these cells
are more sensitive to exogenously supplied cyclic
AMP or to agents which stimulate intracellular
levels of cyclic AMP.
CONCLUSION
From the foregoing discussion of studies that have
been performed in many different laboratories, the
following conclusions can be made .
(a) Additions of cyclic AMP alone do not
stimulate cells to divide except under unique
circumstances in which cells, such as thymo-
cytes, have already been programmed to
undergo cell division.
(b) Increases in cyclic AMP concentrations
(induced either by stimulation of adenylate
cyclase or inhibition of phosphodiesterase or
cyclic AMP additions) in mitogen-stimu-
lated lymphocytes inhibit cell division .
(c) Intracellular levels of cyclic AMP and the
rate of DNA synthesis are inversely related.
(d) Cyclic AMP levels fluctuate throughout the
cell cycle, but the question of whether mito-
gens induce immediate increases in this
nucleotide has not been unequivocally re-
solved.
(e) Cyclic GMP levels are rapidly and exten-
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555increased in mitogen-stimulated
human lymphocytes.
Cyclic AMP inhibits malignant cell growth
to a greater extent than normal cell growth.
A relationship between cyclic AMP and
neoplasia cannot be unequivocally estab-
lished at this time . However, since rapidly
proliferating malignant cells generally have
lower cyclic AMP levels and are more
sensitive to inhibition by additions of cyclic
AMP, a defect in the cyclic AMP system is
a distinct possibility.
What must be considered now
site of action of cyclic AMP within the cell cycle .
Cyclic AMP levels apparently are regulated pro
throughout the cell cycle. Relatively high
to those observed in mitosis)
inhibit the progression of this cycle late in G1, S,
and Ga The question of the role that cyclic AMP
performs in controlling glycogen synthesis and
degradation (Robison et a ., 1971) microtubule
formation (Goodman et al ., 1970) and ribosomal
RNA processing (Walton et al., 1971) in relation-
ship to the cell cycle is currently not understood
but these macrosnolecular processes may represent
points of control. In fact, cyclic AMP may control
DNA synthesis through other critical pathways
which are prerequisites in a sequential manner for
the synthesis of DNA and cell growth . The evi-
dence appears to be clear that cyclic AMP exerts
precise controls and is not merely toxic, causing a
general cell death.
Another consideration is that cyclic AMP may
play a dual role. For example, cyclic AMP could,
at one point in the cell, stimulate phosphorylation
of proteins that regulate the progression of the
cycle but at a later point activate a phosphatase
which in turn cleaves phosphate from the phas-
phorylated protein. Such a mechanism would pro-
vide for the control of replication through a com-
mon small nucleotide by stimulating at one p
and causing inhibition at another. Although it is
speculative at the present time, some evidence
does exist for the role of cyclic AMP in controlling
phosphatase in cells (Koyama et al., 1972 and De
Lorenzo et al, 1973).
In conclusion, the information available
strongly implies a role for cyclic AMP in the regu-
lation of cell growth. The question of how this
cyclic nucleotide exerts its influence upon critical
cellular processes has only begun to be investi-
gated.
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